EPS, Antiparkinsonian Drugs, and TD
Relationship of EPS, Antiparkinsonian Drugs, and TD

Released: July 20, 2021

Expiration: July 19, 2022

John M. Kane
John M. Kane, MD
Rebecca S. Roma
Rebecca S. Roma, MD

Activity

Progress
1
Course Completed

In this episode, John M. Kane, MD, and Rebecca S. Roma, MD, discuss clinical assessment of extrapyramidal symptoms (EPS), antiparkinsonian drugs, and tardive dyskinesia (TD). They review differentiating between TD and EPS, identify tools for diagnosing TD, and provide some important clinical pearls and evidence-based reasons for choosing different medications for treating EPS and TD.

Presenters:

John M. Kane, MD
Professor and Chairman
Department of Psychiatry
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Glen Oaks, New York

Rebecca S. Roma, MD
Medical Director
REACH, LLC
Pittsburgh, Pennsylvania